The canine B-cell lymphoma line CLBL1 was treated with varying concentrations of acalabrutinib for 1 hour, and then stimulated with anti-IgM and subjected to analysis of the BCR signaling pathway. Here, CD40LG is linked to B-cell non-Hodgkin lymphoma.